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Abstract 
Due to the success of antiretroviral (ART) medications, young people living with perinatally 
acquired HIV (PHIV+) are now surviving into adolescence and young adulthood. 
Understanding factors influencing ART non-adherence in this group is important in 
developing effective adherence interventions. Most studies of ART adherence in HIV-
positive populations assess differences in adherence levels and adherence predictors between 
participants, over a period of time (global adherence). Many individuals living with HIV, 
however, including PHIV+ young people, take medication inconsistently. To investigate this 
pattern of adherence, a within-participants design, focussing on specific episodes of 
adherence and non-adherence, is suitable (episodic adherence).  
A within-participants design was used with 29 PHIV+ young people  (17 female, median age 
17 years, range 14-22 years), enrolled in the UK Adolescents and Adults Living with 
Perinatal HIV (AALPHI) cohort study. Participants were eligible if they could identify one 
dose of medication taken and one dose they had missed in the previous two months. For each 
of the two episodes (one adherent, one non-adherent), behavioural factors (whom they were 
with, location, routine, day, reminders) and psychological factors at the time of the episode 
(information about medication, adherence motivation, perceived behavioural skills to adhere 
to medication – derived from the Information-Motivation-Behavioural Skills (IMB) Model – 
and affect) were assessed in a questionnaire.  
 
Non-adherence was significantly associated with weekend days (Friday to Sunday versus 
Monday to Thursday, p=0.001), lack of routine (p=0.004), and being out of the home 
(p=0.003), but not with whom the young person was with or whether they were reminded to 
take medication. Non-adherence was associated with lower levels of behavioural skills 
(p<0.001), and lower positive affect (p=0.005). Non-adherence was not significantly 
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associated with negative affect, information about ART, or ART motivation. The use of 
situationally-specific strategies to enhance adherence in young people who take their 
medication inconsistently is proposed. 
Keywords: antiretroviral; adherence; adolescent; perinatal; young adult
 4 
 
Introduction 
Mortality in HIV-positive people aged 10-19 years, many of whom are living with perinatally 
acquired HIV (PHIV+), is increasing (UNICEF, 2015). This may partly be due to low levels 
of antiretroviral (ART) adherence (Kim, Gerver, Fidler, & Ward, 2014).  It is, therefore, 
important to investigate factors influencing ART non-adherence in young PHIV+ people. 
PHIV+ young people face many challenges, including the HIV-related death or serious 
illness of parents, hospitalisations, missed school and social opportunities, and pain (Mellins 
& Malee, 2013). PHIV+ young people often have long histories of medication use with 
suboptimal regimens and treatment failure (Sohn & Hazra, 2013). Some young PHIV+ 
individuals also have cognitive functioning (Laughton, Cornell, Boivin, & Van Rie, 2013) 
and mental health (Mellins & Malee, 2013) difficulties that may affect ART adherence. 
A number of individual psychological and behavioural factors are associated with ART non-
adherence in young people living with HIV.  These include: the perceived difficulty of 
medication routine (Chandwani et al., 2012); depression (Kacanek et al., 2015; Kang, Delzell, 
Chhabra, & Oberdorfer, 2015; Sheth et al., 2015); substance use (Chandwani et al., 2012); 
lower treatment self-efficacy (Kang et al., 2015; Rudy et al., 2009); negative treatment 
outcome expectancies (Rudy et al., 2009); and forgetting (Chandwani et al., 2012). A number 
of additional individual ‘reasons’ for non-adherence have been cited, including side effects 
(K. E. Macdonell, Naar-King, Murphy, Parsons, & Huszti, 2011), fearing HIV disclosure and 
anticipated stigma (Buchanan et al., 2012; Denison et al., 2015; Rao, Kekwaletswe, Hosek, 
Martinez, & Rodriguez, 2007), not feeling like taking medication and not wanting to be 
reminded of HIV (K.E. Macdonell, Naar-King, Huszti, & Belzer, 2013).  
Forty to 50% of patients across various medical conditions are ‘inconsistently adherent’, 
intentionally or unintentionally skipping doses or taking unplanned breaks (WHO, 2003).   
 5 
 
Similar rates of inconsistent antiretroviral adherence have been reported in HIV-positive 
samples (Carrieri et al., 2001). Within-participant designs allow the investigation of factors 
which may vary according to specific contexts, enable static demographic factors to be 
controlled for and help to explain variability within individuals (Wagner & Ryan, 2004).  
Variation in actual or perceived barriers to or facilitators of adherence can also be measured 
episodically, relating to specific medication events.  Such designs have been used to 
investigate self-efficacy and smoking cessation behaviour (Van Zundert, Engels, & Kuntsche, 
2011) and medication adherence in adults with Beta Thalassaemia Major (Vosper, Evangeli, 
Porter, & Shah, 2013).  
The Information Motivation Behavioural Skills (IMB) model describes behavioural and 
psychological determinants of ART adherence (J. D. Fisher, Fisher, Amico, & Harman, 
2006).  It includes: information, or understanding of the regimen and side effects; motivation, 
both personal motivation, or treatment outcome expectancies and their perceived importance, 
and social motivation, or the perception and importance of others’ wishes in relation to ART 
adherence; and behavioural skills, objective skills in taking medication as well as perceived 
self-efficacy in using those skills (W. Fisher, Fisher, & Shuper, 2014).  Moderating variables 
are included (e.g. mental health issues) (Amico et al., 2009). Each IMB construct might vary 
according to situation, making this model suited to researching differences within individuals 
across contexts.  
This study focuses on situational behavioural and IMB-derived psychological factors and 
ART adherence in young people with PHIV+. It responds to calls for theory-informed ART 
adherence research with young people living with HIV (Simoni et al., 2007). The study also 
addresses a gap in the literature concerning situational determinants of non-adherence. It aims 
to investigate which psychological and behavioural variables differentiate episodes of ART 
adherence and non-adherence in young PHIV+ people. 
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Method 
Design and setting 
An event-level within participant design was used. Participants completed the same measure 
for one adherent and one non-adherent event.  Recruitment was from three clinics (two in 
London, one in Manchester) and a London voluntary-sector organisation. 
Participants 
Participants had previously enrolled in the UK Adolescents and Adults Living with Perinatal 
HIV Infection (AALPHI) cohort study, attending one of the four sites. AALPHI samples 
systematically from 20 sites across the UK. Inclusion criteria are a history of UK paediatric 
care; perinatally acquired HIV; 13-21 years at time of enrolment; and UK resident >6 
months. A systematic sampling approach was also used for this study. All eligible 
participants were approached between December 2014 and April 2015.  Inclusion criteria for 
the current study were as for AALPHI. In addition, participants needed to be on ART, and 
able to recall a taken and missed dose in the preceding two months.   
Thirty six young people were approached, of whom 29 participated. The seven who refused 
to participate cited insufficient time as the reason for not taking part. Anonymous identifiers 
were linked to the AALPHI database for demographic and behavioural characteristics. 
Ethical approval 
Ethical approval was granted by Berkshire B NHS Ethics Committee and Royal Holloway 
University of London Psychology Departmental Ethics Committee. 
Measures  
A self-report questionnaire (available in both paper and pencil and online format) was used. 
Participants were asked how they thought and felt at a time when they did or did not take 
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their medication.  The questionnaire construction was guided by the Day Reconstruction 
Method to reduce recall bias (Kahneman, Krueger, Schkade, Schwarz, & Stone, 2004).  
 
Behavioural variables 
The following behavioural factors were assessed (prior to ratings of situational psychological 
states, to enhance episodic memory detail) for each of the two events: 
 Day  
 Location (home; a friend’s home; partner’s home; public place, e.g., work, school or 
college; family member’s home); 
 Who was with them (alone; with friend; partner; family; acquaintance; work 
colleague); 
 Whether activity was routine (yes/no, if no, was activity planned or unplanned); 
 Whether someone else reminded them to take their medication (yes/no); 
 Use of street drugs or alcohol (yes/no). 
 
Psychological variables 
The questionnaire measured constructs from the IMB model, adapting the LifeWindows 
Information Motivation Behavioural Skills ART Adherence Questionnaire (LW-IMB-AAQ) 
(Life Windows Project Team, 2006). This 33-item scale measures ART adherence barriers.  
The LW-IMB-AAQ has not been used with adolescents (Amico, personal communication). 
The measure was, therefore, adapted for the target group and to be situationally-specific.  
Items not satisfying these criteria were removed and/or adapted. The omitted items were 
presented to a focus group (12 young people from the UK Children’s HIV Association 
(CHIVA) Youth Committee) to corroborate that they had not been erroneously excluded.  
Three information items (from nine), seven motivation items (from ten) and ten behavioural 
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skills items (from fourteen) remained after this process. Extra items were added based on 
other factors found to predict between-participant ART adherence in young PHIV+ people or 
to have been elicited as reasons for non-adherence (Agwu & Fairlie, 2013; K. E. Macdonell 
et al., 2011; Rudy et al., 2010). Four information (e.g., “I knew what medication to take”), ten 
motivation (e.g., “I thought other people would notice I was taking my medication, which 
concerned me”), and eight behavioural skills items (e.g., “I felt confident I could take my 
medicines however I was feeling”) were included in the final 22-item questionnaire.  
Responses were rated on a five point Likert scale (strongly disagree to strongly agree). 
Cronbach’s alpha was calculated for subscales for each episode. Further analysis assessed 
whether subscales could be refined to improve psychometric properties.  For the motivation 
subscale, alpha improved from 0.79 to 0.85 for non-adherent episode and 0.76 to 0.87 for 
adherent episode, if two items were dropped.  The item-total correlations for these items were 
low.  An eight-item Personal Motivation scale was, therefore, used for analysis.  One of the 
two dropped items measured social motivation (“People around me that I care about were 
supportive about my medication”). This was analysed separately. The behavioural skills and 
information subscales did not require modifications (information adherent episode α=0.98; 
information non-adherent α=0.71; behavioural skills adherent α=0.71; behavioural skills non-
adherent α=0.83).    
 
Affect was assessed by adapting the Positive and Negative Affect Schedule (PANAS-C) – 10 
item Children’s Version (Ebesutani et al., 2011), to be relevant to a specific event. This scale 
has two five-item subscales (positive and negative affect). In our sample, internal consistency 
was excellent (adherent episode: positive affect α=0.91, negative affect α=0.86; non-adherent 
episode: positive affect α=0.94, negative affect α=0.93). An additional four negative affect 
items were suggested by the focus group: feeling blamed, helpless, out of control and weak. 
 9 
 
To avoid bias towards negative affect items, an additional four positive affect items were  
added, derived from a critique of the PANAS (Peterson et al., 2013) (calm, content, at ease 
and satisfied) measuring non-activated positive affect. 
 
Intentional adherence for the adherent episode was measured with the item, “Taking the 
medicines was my choice”. Non-intentional non-adherence was measured with the item, “I 
forgot”. Somatic symptoms (both episodes) were measured with a single item, “I felt ill”. 
These items used five-point Likert scales (strongly disagree to strongly agree).  
 
Procedure 
AALPHI research nurses introduced the study to eligible participants whom had already 
enrolled and completed their first AALPHI interview. Occasional ART non-adherence was 
normalised. People wishing to participate could consent and complete the questionnaire in 
writing or online.  Online consent was carried according to national guidelines (BPS, 2013).  
Event order was counter-balanced to control for order effects.  Participants received £10 for 
taking part. 
Analysis 
Skewed continuous variables were transformed for parametric analysis. Bivariate analysis 
compared adherent and non-adherent episodes.  Variables meeting assumptions for 
parametric statistics were analysed using paired-samples t-tests.  Categorical variables were 
analysed using McNemar’s chi square tests (using Fisher’s exact estimates for expected 
frequencies <5). Effect sizes were calculated using Cramer’s phi (ϕ) for categorical variables 
(small effect 0.1; medium effect 0.3; large effect 0.5) and Cohen’s d for comparisons of 
means (small effect 0.2; medium effect 0.5; large effect 0.8) (Cohen, 1992).  
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Results 
Demographic information is presented in Table 1.  
Table 1 here 
Participants were predominantly female (17/29: 59%), born in Africa (20/29: 69%), of Black 
African ethnicity (25/28: 89%), with a median age of 17 years. These characteristics are 
similar to UK national data on paediatric HIV (51% female; 52% born abroad; 79% Black 
African)(CHIPS, 2014). Table 2 presents clinical and behavioural characteristics at AALPHI 
enrolment (median days prior to this study = 468).  
Table 2 here 
Participants were mostly on once a day regimens (24/25). Self-reported adherence was 
predominantly excellent or good (23/25). The majority had shared their HIV status with 2 or 
fewer individuals (21/26). One participant had been referred to child mental health services. 
The majority did not drink alcohol (18/28). 
 
The median rating of “Taking the medicines was my choice” for adherent episode was 5 (IQR 
3.75-5). The median rating of “I forgot” for non-adherent episode was 4 (IQR=2.25-5).   
Relationships between behavioural variables and non-adherence  
Table 3 presents descriptive statistics for behavioural variables and adherence. 
Table 3 here 
There was a significant relationship between non-adherence and weekend days (Friday to 
Sunday) (p=.001; ϕ=0.65, large effect size). Participants were significantly more likely to be 
non-adherent on a day when the routine was different to normal (p=.004, ϕ=0.59, large 
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effect). The non-adherent event was more likely when participants were out of the home 
(p=.003, ϕ=0.58, large effect). Non-adherence was neither associated with whom the young 
person was with (p=0.34, ϕ = 0.24) nor having someone to remind them to take medication 
(p=0.63, ϕ=0.19).  Substance use difference between episodes were not analysed due to very 
low levels of substance use. 
Relationships between psychological variables and adherence  
Table 4 presents descriptive statistics for information, motivation and behavioural skills 
subscales. 
Table 4 here 
There were no significant differences between adherent and non-adherent episode on the 
information subscale (reverse log transformed due to negative skew) (p=0.28, d=0.06) or 
personal motivation subscale (p=0.78, d=0.04).  The relationship between higher social 
motivation and non-adherence approached significance (p=0.07; d=.38, small to medium 
effect).  The difference in behavioural skills between episodes was highly significant, with 
participants rating their abilities in taking medication lower for the non-adherent episode 
(p<0.001; d=0.91, large effect). 
 
Table 5 presents descriptive statistics for affective and somatic variables. 
Table 5 here 
Young people rated their positive emotions (measured by the PANAS-C Positive Affect five-
item scale) more highly for adherent episode (p=0.005, d=0.61, medium to large effect). All 
additional positive affect items: feeling calm (p=0.01, d=0.63); at ease (p=0.03, d=0.49); 
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content (p=0.03, d=0.48); and satisfied (p=0.02, d=0.51), were rated significantly higher for 
adherent episode (medium or medium to large sized effects). 
Negative affect (measured by the PANAS-C Negative Affect five-item scale) was not 
associated with non-adherence (p=0.08 d=0.36, small to medium effect). Of the additional 
negative affect items, feeling weak (p=0.40, d=0.12), log transformed helpless (p=0.13, 
d=0.27), and out of control (p=0.11, d=0.29) were not rated differently between episodes. 
Feeling blamed, however, was significantly higher for non-adherent episode (p=0.004, 
d=0.73, medium to large effect).   
 
There was no significant difference in reports of feeling ill between episodes (p=0.76, 
d=0.06). 
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Discussion 
This study represents an initial exploration of situational psychological and behavioural 
correlates of episodic medication adherence amongst young PHIV+ people.  Non-adherence 
was strongly associated with lower perceived behavioural skills at the time of the episode. 
The behavioural skills construct in the IMB model includes having the confidence and skill to 
self-cue and self-administer ART, incorporate ART into daily routines, manage possible 
unwanted effects and reinforce oneself for ongoing adherence (W. Fisher et al., 2014).  Our 
findings are consistent with the model, which proposes that behavioural skills are the most 
proximal factor to adherence (J. D. Fisher, Amico, Fisher, & Harman, 2008).  Our findings 
also suggest that perceived behavioural skills vary situationally. Relationships between 
higher levels of self-efficacy (closely related to perceived behavioural skills) and ART 
adherence have been demonstrated between participants in the PHIV+ population (Kang et 
al., 2015; Rudy et al., 2010).  Bandura suggested that higher self-efficacy produces greater 
effort and persistence in solving problems when facing challenges (Bandura, 1986).  Our 
participants may have faced different situational challenges, which subsequently impacted on 
effort and self-confidence in adhering to ART at that time. 
Non adherence was not associated with the other central constructs of the IMB model 
(information and motivation). The lack of difference in information scores between episodes 
may have been due to a ceiling effect.  In the IMB model, information is essential for 
adequate adherence (W. Fisher et al., 2014).  ART-related knowledge may be necessary but 
not sufficient for adherence. Non-adherence was also not associated with ART motivation, 
consistent with findings with adults with Beta Thalassaemia Major using a similar within-
participant methodology (Vosper et al., 2013) but in contrast to between-participant findings 
in young people with PHIV+ (Rudy et al., 2009).  
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Non-adherence was associated with lower activated (e.g., “I feel happy”) and non-activated 
(e.g., “I feel calm”) positive affect. Examining positive affect in relation to adherence is 
rarely reported in the literature. Non-adherence was not significantly associated with negative 
affect, although this may be due to low statistical power. Studies in adults have also failed to 
find a relationship between negative affect and ART adherence (Gonzalez et al., 2007).  
There was an association between feeling blamed and non-adherence, although it is not clear 
whether feeling blamed occurred before or after non-adherence. 
Non-adherence was significantly associated with weekend days, lack of routine and being out 
of the home.  Being away from home has been cited as a reason for non-adherence (Denison 
et al., 2015), and having a routine has been cited as a reason for ART adherence in HIV+ 
adolescents (Kim, McDonald, Kim, Foster, & Fidler, 2015). Lower adherence levels  at 
weekends have prompted trials of regimens that do not include weekend doses (Butler, 2015). 
The differences between episodes on behavioural variables suggest difficulty in adhering in 
particular contexts.  Different daily activity may have interfered with adherence planning and 
cueing.  Psychological variables found to vary between episode (behavioural skills and 
positive affect, in particular) may have mediated the relationship between situation and 
adherence.  For example, young people might feel more confident in particular contexts, 
which then facilitates adherence.  This could not be tested statistically due to our small 
sample. 
This study was limited by the use of non-standardised measures, whose psychometric 
properties should be established in larger samples. The small sample size meant that there 
was limited statistical power to detect significant differences and precluded any multivariable 
analysis. The study benefited from systematic sampling and a good response rate (81%). 
There may, however, have been differences between those who participated and those who 
chose not to take part which biased the findings.  
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Future research could assess whether companions at the time of the episode are aware of the 
young person’s HIV status. PHIV+ young people have reported not taking ART to avoid 
disclosing their diagnosis (Denison et al., 2015).  Associations between onward disclosure 
and less hiding of medication have been found in PHIV+ children and adolescents (Calabrese 
et al., 2012).  Larger samples could enable analysis of adherence predictors between ages, 
support multivariable analysis and allow comparison of predictors of intentional versus 
unintentional non-adherence. Forgetting may be a particularly pertinent factor in episodic 
non-adherence in this population. With changes to usual routine and location, an absence of 
relied-upon cues would necessitate a greater reliance on working memory, which may be 
impaired in the PHIV+ population (Laughton et al., 2013). Prospective studies, using 
ecological momentary assessment of adherence episodes, could enhance measurement 
reliability and validity (Shiffman, Stone, & Hufford, 2008). 
Clinically, assessments of barriers to and facilitators of adherence could focus on situational 
variations in cognitions and affect. A greater understanding of situational factors implicated 
in non-adherence would help clinicians and young people in considering strategies to manage 
situations with a greater risk of non-adherence. This work could use the concepts of action 
planning (developing when, where and how elements of goal-directed behaviour) and coping 
planning (anticipating barriers and planning alternative actions to attain one’s goals) 
(Sniehotta, Scholz, & Schwarzer, 2006).  
A focus on facilitators (as well as barriers) to adherence is consistent with psychological 
interventions, including Motivational Interviewing and Cognitive Behaviour Therapy 
(Mbuagbaw et al., 2015). This study highlights perceived behavioural skills as potentially 
critical for episodic ART adherence, suggesting that key areas for intervention could be: 
improving confidence to overcome barriers, promoting abilities in acquiring personal and 
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social support, incorporating ART into daily life, self-cueing and self-reinforcement to adhere 
to ART (J. D. Fisher et al., 2006).  
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Table 1: Demographic information (n=29) 
Variable   
Age Median 17 
 
IQR 16-18.5 
Gender Female 17  
Birthplace UK/Europe 9 
 
Africa  20 
Ethnicity Black African 25  
 
Other  3 
 
Prefer not to say 1 
 
Table 2: Clinical and behavioural characteristics (n=29) 
Variable   Frequencies 
Medication ART once daily  24 
 
ART twice daily  1 
 
Missing  4 
Adherence Subjective rating of 
overall adherence 
Excellent 12 
 
Good 11 
 
Not so good 2 
 
 Missing 4 
HIV Disclosure Number of people 
disclosed to 
10+ 3 
 
5-9 1 
 
3-4 1 
 
1-2 10 
 
0 11 
 
 Missing 3 
Referred to 
child mental 
health 
services? 
Yes  1 
No  24 
Missing  4 
Alcohol use Never  18 
 
Monthly or less  6 
 
2-4 times/month  2 
 
4+ times/week  2 
 
Missing  1 
 
Table 3: Descriptive statistics for behavioural variables (n=29) 
Variable  Non-adherent episode 
 (frequencies) 
Adherent episode 
 (frequencies) 
p value* 
Weekday  Mon-Thu 11  22  0.001 
Fri-Sun 16  5  
Missing 2  2  
Routine  Normal 12 Same 
12 
24 Same  
24 
0.004 
 
Unexpected 8 Different  
15 
2 Different  
4 
 
 
Planned 7 2 
 
Missing 2  1  
Location  At home 15  25  0.003 
 
Not at 
home 
14  3  
 
Missing 0  1  
Who with at 
time of 
dose/missed 
dose 
Alone 8 Alone 
 8 
12 Alone  
12 
0.34 
Friend 10 Not alone 
21 
0 Not alone 
16 
 
Partner 2 0 
Family 9 16 
Missing 0  1  
Someone 
there to 
remind you 
Yes 11  9  0.63 
No 18 19 
Missing 0 1 
Substance use Yes 4  2  
 
No 25 26 
Missing 0 1 
*p value of difference between non-adherent and adherent episode 
Table 4: Descriptive statistics for Information, Motivation, and Behavioural Skills 
Variable 
(minimum-
maximum score) 
Episode Mean SD p value* 
Information  
(4-20) 
Non-adherent 18.04 3.64 0.28 
Adherent 19.04 1.64 
Personal 
Motivation 
(8-40) 
Non-adherent 21.14 8.59 0.78 
Adherent 21.54 8.06 
Social Motivation  
(1-5) 
 
Non-adherent 2.52 1.33 0.07 
Adherent 2 1.28 
Behavioural Skills  
(10-50) 
Non-adherent 29.75 9.52 <0.001 
Adherent 37.92 7.29 
*p value of difference between non-adherent and adherent episode 
 
Table 5: Descriptive statistics for affective and somatic variables 
Variable 
(min-max score) 
Episode Mean  
(SD) 
p value* 
PANAS-C 5 item 
Positive Affect (5-25) 
Non-adherent 8.55 (4.55) 0.005 
Adherent 12.15(6.02) 
Calm 
(1-5) 
Non-adherent 2.34 (1.32) 0.01 
Adherent 3.33 (1.49) 
At ease 
(1-5) 
Non-adherent 2.28 (1.31) 0.03 
Adherent 3.07 (1.54) 
Content 
(1-5) 
Non-adherent 2.14 (1.19) 0.03 
Adherent 2.85(1.43) 
Satisfied 
(1-5) 
Non-adherent 2.17(1.34) 0.02 
Adherent 3.00 (1.54) 
PANAS-C 5 item 
Negative Affect (5-25) 
Non-adherent 11.34(5.97) 0.08 
Adherent 8.96 (5.25) 
Weak Non-adherent 2.10 (1.21) 0.40 
(1-5) Adherent 2.00 (1.44) 
Helpless Non-adherent 2.17 (1.47) 0.13 
(1-5) Adherent 1.77 (1.07) 
Out of control 
(1-5) 
Non-adherent 2.21 (1.40) 0.11 
Adherent 1.93 (1.36) 
Blamed Non-adherent 2.17 (1.39) 0.004 
(1-5) Adherent 1.41 (0.80) 
Somatic symptoms 
“I felt ill”(1-5) 
Non-adherent 2.52 (1.37) 0.76 
Adherent 2.54 (1.38) 
*p value of difference between non-adherent and adherent episode 
